Treatment Details
  • Treatment Details
  • Directions
  • Side Effects
  • Important Information
  • What are Malarone Tablets?
    Malarone Tablets are a prescription medication used to prevent malaria, a serious and sometimes fatal disease transmitted by mosquitoes in certain tropical and subtropical regions. Malarone combines two active ingredients, atovaquone and proguanil, which work together to prevent the malaria parasite from reproducing and spreading in the body.

    How do Malarone Tablets work?
    Atovaquone and proguanil, the active ingredients in Malarone, work synergistically to disrupt the life cycle of the malaria parasite. Atovaquone inhibits mitochondrial electron transport, while proguanil enhances its effect by inhibiting dihydrofolate reductase, both of which are crucial for the parasite's survival. This combination prevents the parasite from multiplying in the liver and bloodstream.

    Additional Information

    Onset of Action: Start taking 1-2 days before entering a malaria-endemic area.
    Duration of Effect: Continue taking the medication daily while in the area and for 7 days after leaving.

  • How to Use Malarone Tablets:

    • Take one tablet daily with food or a milky drink.
    • Start 1-2 days before entering the malaria risk area and continue daily during your stay and for 7 days after leaving.
    • Do not exceed the recommended dosage.

    Important Information:

    • Not recommended for individuals with severe kidney disease.
    • Consult a doctor before use if pregnant, breastfeeding, or taking other medications.
    • Use in combination with other malaria prevention methods like mosquito repellent and nets.
  • Common side effects may include:

    • Nausea
    • Vomiting
    • Abdominal pain
    • Headache
    • Dizziness

    Serious side effects are rare but may include allergic reactions or severe skin rashes. Discontinue use and seek medical advice if severe symptoms occur.

  • Before taking Malarone Tablets, please read the Patient Information Leaflet (PIL). It provides essential details on dosage, side effects, and safe use.

    For complete information, refer to the Malarone Patient Information Leaflet (PIL).

Frequently asked questions
  • What conditions do Malarone Tablets help prevent?

    Malarone Tablets are specifically designed to prevent malaria, a life-threatening disease transmitted by infected mosquitoes in high-risk tropical and subtropical regions. The combination of atovaquone and proguanil effectively targets the malaria parasite, making Malarone a reliable choice for travelers seeking comprehensive malaria prevention.

  • How often should I take Malarone Tablets?

    You should take one Malarone tablet daily, beginning 1-2 days before entering a malaria-endemic area. Continue taking it every day during your stay and for 7 days after leaving the area. This consistent dosing ensures the medication remains effective in preventing malaria throughout your travels.

  • Are Malarone Tablets safe for children?

    Malarone is safe for children, with a pediatric formulation available. The dosage for children is based on their weight, so it's essential to consult a healthcare professional for the appropriate dosing. This makes Malarone a trusted option for families traveling to malaria-prone regions.

  • Can I take Malarone Tablets with other medications?

    Malarone can interact with other medications, so it's crucial to consult a healthcare professional before combining it with other drugs, especially other anti-malarial medications or those affecting liver function. Proper guidance ensures Malarone’s effectiveness while minimising potential risks.

  • What should I do if I experience side effects from Malarone Tablets?

    Common side effects of Malarone may include nausea, vomiting, and headaches. If these side effects occur, continue taking the medication and inform your doctor. For severe symptoms such as allergic reactions or severe skin rashes, discontinue use and seek immediate medical attention to ensure safety during malaria prevention.

Copyright 2025